Approval · Notice of Compliance 37952 · 2026

FENTORA: Notice of Compliance 37952

Issued July 22, 2026

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 37952
Date: July 22, 2026
Company: Phoenix Labs Unlimited CompanyDublin, Ireland
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Reason: Administrative: Change in product ownership

Products in this notice

Brand	DIN	Status today
FENTORA	02408007	Marketed
FENTORA	02408015	Marketed
FENTORA	02408023	Marketed
FENTORA	02408031	Marketed
FENTORA	02408058	Marketed

Medicinal ingredients

FENTANYL CITRATE 100 MCG per TAB
FENTANYL CITRATE 200 MCG per TAB
FENTANYL CITRATE 400 MCG per TAB
FENTANYL CITRATE 600 MCG per TAB
FENTANYL CITRATE 800 MCG per TAB